U.S. Markets open in 1 hr, 45 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 8,451.19 | -128.00 | -1.49% |
| NASDAQ | 1,649.51 | 4.39 | 0.27% |
| S&P 500 | 899.22 | -10.70 | -1.18% |
| Day Low 02:02 PM EDT | 41.90 | |
|---|---|---|
| Day High | 47.50 |
|
| Range | 5.60 | |
| Volume | 481,197 | |
| 30-Day Avg. Vol. | 311,000 |
|
| Difference | 54.73% | |
| Market Cap. | 23.17 B | |
| Change | -247.46 M | |
| Shares Out. | 513.65 M | |
| Percent Traded | 0.09% | |
| Revenue (LFY) | 7.74 B | |
| Earnings (TTM) | 1.57 B | |
| Next Earnings | 10/31/2008 |
|
| EPS (TTM) | 2.49819 |
| 52-Wk Low 10/10/08 | 41.90 | |
|---|---|---|
| 52-Wk High 4/8/08 | 73.73 |
|
| Range | 31.83 | |
| Prev. Close 10/9/08 | 44.49 | |
| Today's Open | 45.05 | |
| Change | 1.26% | |
| Dividend (TTM) | 0.94232 | |
| Div. Yield (TTM) | 2.14% |
|
| Beta | 0.5702 | |
| P/E Ratio (TTM) | 17.89 | |
| P/E Ratio (Fwd.) | 14.00 |
Novo Nordisk can tell diabetics where to stick it. One of the world's leading producers of insulin, Novo Nordisk also makes insulin analogues, injection devices, and diabetes education materials. Its products ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| 2 Quarters Ago | — 3/31/08 | 0.70 3/31/08 |
—
—
|
| Last Quarter | — 6/30/08 | 0.83 6/30/08 |
—
—
|
| Quarterly - 06/30/2008 | Annual - 2007 | |
|---|---|---|
| Total Revenue | 2.33 B | 7.75 B |
| Gross Profit | 1.79 B | 7.08 B |
| Operating Income | 612.88 M | 1.85 B |
| Net Income | 517.40 M | 1.58 B |
